CANCvsBBPETF Comparison
VS
Tema Oncology ETF (CANC) and Virtus LifeSci Biotech Products ETF (BBP) belong to the same industry segment: Tomorrow's Treatments. Both ETFs have the same top 3 sector exposures: and Health Care. CANC is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.79% for BBP. CANC is up 8.22% year-to-date (YTD) with +$52M in YTD flows. BBP performs better with 9.25% YTD performance, and +$30M in YTD flows. Run a side-by-side ETF comparison of CANC and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
CANC vs BBP performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 06/12/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | CANC BBP | -0.48%-1.38% | +3.95%+7.00% | +8.22%+9.25% | +45.49%+43.65% | n/a+60.05% | n/a+58.90% |
| Flows | CANC BBP | +$5M+$4M | +$11M+$26M | +$52M+$30M | +$69M+$42M | -+$45M | -+$38M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | CANC BBP | +24.37%+28.75% | +22.62%+24.06% | n/a+24.00% | n/a+26.36% |
| Max drawdown | CANC BBP | -9.20%-7.49% | -9.20%-9.59% | n/a-25.54% | n/a-37.87% |
| Max drawdown duration | CANC BBP | 54d37d | 54d48d | n/a292d | n/a760d |
Trading data
CANC | BBP | |
Last sale 6/12/2026 at 1:30 PM | $37.48 | $87.17 |
| Previous close 06/11/2026 | $37.26 | $86.80 |
| Consolidated volume 06/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of May 29, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
CANC
is actively managed and doesn’t replicate an indexCANC | BBP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 6/12/2026 at 1:30 PM
Live
Closed
CANC | BBP | |
|---|---|---|
| Last price | $37.48 | $87.17 |
| 1D performance | +0.60% | +0.42% |
| AuM | $178.42 M | $78.43 M |
| E/R | 0.99% | 0.79% |
Characteristics
CANC | BBP | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Tema | VIRTUS Investment Partners |
| Benchmark | - | LifeSci Biotechnology Products Index |
| N° of holdings | 42 | 55 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | August 15, 2023 | December 16, 2014 |
| ESG | No | No |
Advertisement
Exposure
Countries
CANC
USA
87.11%
Other
12.89%
BBP
USA
84.13%
Other
15.87%
Sectors
CANC
Health Care
76.64%
Other
23.36%
BBP
Health Care
85.97%
Other
14.03%
Advertisement
Diversification
CANC
Total weight of top 15 holdings out of 15
54.47%
BBP
Total weight of top 15 holdings out of 15
45.32%
Top 15 holdings
Data as of April 30, 2026
CANC
REVOLUTION MEDICINES INC
6.51%
IMMUNOME
4.24%
US7711951043
4.15%
COGENT BIOSCIENCES
4.07%
NOVARTIS
4.00%
LILLY
3.81%
ASTRAZENECA
3.62%
BRISTOL-MYERS SQUIBB
3.36%
MERCK & CO INC
3.34%
CELCUITY INC
3.31%
NUVALENT
3.20%
BRIDGEBIO PHARMA
2.84%
US3723032062
2.82%
LEGEND BIOTECH
2.63%
US98887Q1040
2.57%
BBP
ARROWHEAD PHARMACEUTICALS INC
3.17%
GB00BRXB0C07
3.17%
BIOGEN INC
3.14%
HALOZYME THERAPEUTICS
3.13%
AURINIA PHARMACEUTICALS INC
3.12%
SYNDAX PHARMACEUTICALS INC
3.12%
BIOMARIN PHARMACEUTICAL
3.05%
INCYTE
3.03%
REGENERON PHARMACEUTICALS
3.03%
BRIDGEBIO PHARMA
3.00%
SAREPTA THERAPEUTICS INC DE
2.95%
ARDELYX
2.92%
VERTEX PHARMACEUTICALS
2.85%
US07725L1026
2.83%
THERAVANCE BIOPHARMA
2.80%
Frequently asked questions about CANC and BBP
How have the CANC and BBP ETFs performed in 2026?
As of June 12, 2026, CANC is up 8.22% year-to-date (YTD), while BBP has returned 9.25%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: CANC or BBP?
Year-to-date, the CANC ETF saw +$52M in flows, compared to +$30M for BBP.
Which ETF is more volatile: CANC or BBP?
Over the past year, CANC had a volatility of 22.62%, while BBP experienced 24.06%.
Which ETF is bigger: CANC or BBP?
As of June 12, 2026, CANC holds $178.42 M in assets under management (AUM), while BBP manages $78.43 M.
What sectors do the CANC and BBP ETFs invest in?
CANC leans toward sectors like Health Care. Meanwhile, BBP focuses on Health Care.
What are the top holdings of the CANC ETF and BBP ETF?
CANC top holdings include REVOLUTION MEDICINES INC, IMMUNOME and US7711951043. BBP holds in its top three: ARROWHEAD PHARMACEUTICALS INC, GB00BRXB0C07 and BIOGEN INC.
Which ETF is more diversified: CANC or BBP?
CANC holds 53 securities with 54.47% of its assets in the top 15. BBP has 59 securities and a top 15 weight of 45.32%.
Advertisement
Advertisement
